Oxcarbazepine
Oxcarbazepine Oxcarbazepine (OX) is an antiepileptic/anticonvulsant commonly used to treat epilepsy, but also exhibits activity as a treatment for mood disorders and neuropathic pain as well. Administration of oxcarbazepine leads…
2017
Oxazolidine Cabazitaxel
Oxazolidine Cabazitaxel Oxazolidine Cabazitaxel is an impurity in the synthestis of the ani-cancer compound, Cabazitaxel. References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18951572 Cas No. 1373171-12-0 Purity ≥95% Formula C48H61NO14 Formula Wt. 875.41 Synonym (4S,5R)-2,2-Dimethyl-4-phenyl-3,5-oxazolidinedicarboxylic…
Oxaliplatin
Oxaliplatin Oxaliplatin is a platinum-based cross-linking agent that exhibits anticancer chemotherapeutic activity. Oxaliplatin inhibits DNA replication and transcription and is clinically used to treat colon cancer. In hepatocellular carcinoma cells,…
Oxacillin Sodium Monohydrate
Oxacillin Sodium Monohydrate Oxacillin is a β-lactam antibiotic that exhibits antibacterial efficacy against some strains of methicillin-resistant or vancomycin-resistant Staphylococcus aureus. References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18951509 Cas No. 7240-38-2 Purity ≥98% Formula…
Ovalbumin Fragment (323-339)
Ovalbumin Fragment (323-339) Ovalbumin (323-339) is an antigenic peptide fragment of ovalbumin that contains a CD4+ T cell epitope. This fragment is an MHC II-restricted epitope that is used in…
Ovalbumin Fragment (257-264)
Ovalbumin Fragment (257-264) Ovalbumin (257-264) is an antigenic peptide fragment of ovalbumin that contains a CD8+ cytotoxic T-cell (CTL)-specific epitope with the sequence ‘SIINFEKL.’ This fragment is administered in vaccines…
OTX-015
OTX-015 OTX-015 is an inhibitor of bromodomains (BRD) proteins such as BRD2/3/4; it is currently in clinical trials as a potential treatment for leukemias and other cancers. OTX-015 displays anticancer…
Osthole
Osthole Osthole is an O-methylated coumarin that inhibits Ca2+ channels. It exhibits anticancer, antioxidative, anti-inflammatory, and cardioprotective activities. In glioblastoma cells, osthole inhibits IGF-1-induced epithelial-to-mesenchymal transition (EMT), decreases phosphorylation of…
OSI-906
OSI-906 OSI-906 inhibits IGF-1R and InsR, displaying anticancer chemotherapeutic activity; it is currently in clinical trials as a potential treatment for colorectal cancer. In animal models of ovarian cancer, OSI-906…
OSI-027
OSI-027 OSI-027 is an inhibitor of mTORC1/2 that exhibits anticancer chemotherapeutic activity. In vitro, OSI0027 inhibits phosphorylation of downstream target Akt, inhibiting cell proliferation in breast cancer cells. OSI-027 also…